Fat Modification in the Diabetes Diet

Abstract

The modification of dietary fat in the diet of diabetic patients is of interest with respect to metabolic and other consequences of this modification. To begin with the data are reviewed for the use of monounsaturated fatty acids (MUFA) in the diabetes diet. Compared to a carbohydrate-rich diet, glucose concentrations are lower. Blood pressure was also found to be lower. There were no major differences with respect to lipid concentrations. HDL-cholesterol levels tended to be higher after a MUFA-rich diet. In type-1 diabetic patients, the number of circulating big VLDL particles was greater after a MUFA diet than after a carbohydrate-rich diet. Comparisons were also made between diets enriched with MUFA and with polyunsaturated fatty acids (PUFA). With respect to lipid concentrations, different groups observed different effects. While one group saw no differences in fasting lipids, they measured a higher remnant-like particle cholesterol after a diet enriched with MUFA. Another group found higher total and LDL-cholesterol levels after a PUFA-rich diet than after a MUFA-diet. In their study, fasting glucose, insulin and fasting chylomicrons and postprandial chylomicrons and VLDL were higher following the PUFA diet. A MUFA-rich diet increased endothelium-dependent flow-mediated dilatation in the superficial femoral artery. Alpha-linolenic acid appears to be a precursor of eicospentaenoic and docosahexaenoic fatty acids. As a diet rich in n-6 PUFA reduces this conversion, a n-6/n-3 PUFA ratio not exceeding 4 - 6 should be observed. No prospective data are available for alpha-linolenic acid in diabetic patients. The review summarizes the results of the Lyon Diet Heart Study and the Nurses' Health Study. Both studies saw a reduced cardiovascular risk associated with a higher intake of alpha-linolenic acid. Finally, data on the effects of fish oil are given. The latter has a clearly expressed triglyceride-lowering effect. Data with respect to glucose control are heterogeneous. Major studies did not find any influence in glucose concentrations. Hepatic glucose production and peripheral insulin sensitivity remained constant. Evidently, nerve function can be improved by fish oil. Data have been compiled comparing the effects of fish oil with those of olive oil, linseed oil and sunflower oil.

Monounsaturated fatty acids - Alpha-linolenic acid - n-3 Fatty acids - Nutrition - Diabetes

References

• 1 Annuzzi G, Rivellese A, Capaldo B, Di Marino L, Iovine C, Marotta G, Riccardi G. A controlled study on the effects of n-3 fatty acids on lipid and glucose metabolism in non-insulin-dependent diabetic patients.  Atherosclerosis. 1991;  87 65-73
• 2 Brynes A E, Edwards C M, Jadhav A, Ghatei M A, Bloom S R, Frost G S. Diet-induced change in fatty acid composition of plasma triacylglycerols is not associated with change in glucagon-like peptide 1 or insulin sensitivity in people with type 2 diabetes.  Am J Clin Nutr. 2000;  72 1111-1118
• 3 Campbell L V, Marmot P E, Dyer J A, Borkman M, Storlien L H. The high-monounsaturated fat diet as a practical alternative for NIDDM.  Diabetes Care. 1994;  17 177-182
• 4 de Lorgeril M, Salen P, Martin J L, Monjaud I, Delaye J, Mamelle N. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study.  Circulation. 1999;  99 779-785
• 5 Diabetes and Nutrition Study Group (DNSG) of the European Association for the Study of Diabetes (EASD) . Recommendations for the nutritional management of patients with diabetes mellitus.  Eur J Clin Nutr. 2000;  54 353-355
• 6 Donaghue K C, Pena M M, Chan A K, Blades B L, King J, Storlien L H, Silink M. Beneficial effects of increasing monounsaturated fat intake in adolescents with type 1 diabetes.  Diabetes Res Clin Pract. 2000;  48 193-199
• 7 Georgopoulos A, Bantle J P, Noutsou M, Hoover H A. A high carbohydrate versus a high monounsaturated fatty acid diet lowers the atherogenic potential of big VLDL particles in patients with type 1 diabetes.  J Nutr. 2000;  130 2503-2507
• 8 Gerster H. Can adults adequately convert alpha-linolenic acid (18: 3 n-3) to eicosapentaenoic acid (20: 5 n-3) and docosahexaenoic acid (22: 6 n-3)?.  Int J Vitam Nutr Res. 1998;  68 159-173
• 9 GISSI-Prevenzione Investigators . Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial.  Lancet. 1999;  354 447-455
• 10 Goh Y K, Jumpsen J A, Ryan E A, Clandinin M T. Effect of omega 3 fatty acid on plasma lipids, cholesterol and lipoprotein fatty acid content in NIDDM patients.  Diabetologia. 1997;  40 45-52
• 11 Higashi K, Shige H, Ito T, Nakajima K, Ishikawa T, Nakamura H, Ohsuzu F. Effect of a low-fat diet enriched with oleic acid on postprandial lipemia in patients with type 2 diabetes mellitus.  Lipids. 2001;  36 1-6
• 12 Hu F B, Stampfer M J, Manson J E, Rimm E B, Wolk A, Colditz G A, Hennekens C H, Willett W C. Dietary intake of alpha-linolenic acid and risk of fatal ischemic heart disease among women.  Am J Clin Nutr. 1999;  69 890-897
• 13 Ilic S, Jovanovic L, Pettitt D J. Comparison of the effect of saturated and monounsaturated fat on postprandial plasma glucose and insulin concentration in women with gestational diabetes mellitus.  Am J Perinatol. 1999;  16 489-495
• 14 Low C C, Grossman E B, Gumbiner B. Potentiation of effects of weight loss by monounsaturated fatty acids in obese NIDDM patients.  Diabetes. 1996;  45 569-575
• 15 Luo J, Rizkalla S W, Vidal H, Oppert J M, Colas C, Boussairi A, Guerre-Millo M, Chapuis A S, Chevalier A, Durand G, Slama G. Moderate intake of n-3 fatty acids for 2 months has no detrimental effect on glucose metabolism and could ameliorate the lipid profile in type 2 diabetic men. Results of a controlled study.  Diabetes Care. 1998;  21 717-724
• 16 Luscombe N D, Noakes M, Clifton P M. Diets high and low in glycemic index versus high monounsaturated fat diets: effects on glucose and lipid metabolism in NIDDM.  Eur J Clin Nutr. 1999;  53 473-478
• 17 Madigan C, Ryan M, Owens D, Collins P, Tomkin G H. Dietary unsaturated fatty acids in type 2 diabetes: higher levels of postprandial lipoprotein on a linoleic acid-rich sunflower oil diet compared with an oleic acid-rich olive oil diet.  Diabetes Care. 2000;  23 1472-1477
• 18 McManus R M, Jumpson J, Finegood D T, Clandinin M T, Ryan E A. A comparison of the effects of n-3 fatty acids from linseed oil and fish oil in well-controlled type II diabetes.  Diabetes Care. 1996;  19 463-467
• 19 Mori T A, Vandongen R, Masarei J R, Rouse I L, Dunbar D. Comparison of diets supplemented with fish oil or olive oil on plasma lipoproteins in insulin-dependent diabetics.  Metabolism. 1991;  40 241-246
• 20 Nakamura N, Hamazaki T, Kobayashi M, Ohta M, Okuda K. Effects of eicosapentaenoic acids on remnant-like particles, cholesterol concentrations and plasma fatty acid composition in patients with diabetes mellitus.  In Vivo. 1998;  12 311-314
• 21 Okuda Y, Mizutani M, Ogawa M, Sone H, Asano M, Asakura Y, Isaka M, Suzuki S, Kawakami Y, Field J B, Yamashita K. Long-term effects of eicosapentaenoic acid on diabetic peripheral neuropathy and serum lipids in patients with type II diabetes mellitus.  J Diabetes Complications. 1996;  10 280-287
• 22 Popp-Snijders C, Schouten J A, Heine R J, van der Meer J, van der Veen E A. Dietary supplementation of omega-3 polyunsaturated fatty acids improves insulin sensitivity in non-insulin-dependent diabetes.  Diabetes Res. 1987;  4 141-147
• 23 Puhakainen I, Ahola I, Yki-Jarvinen H. Dietary supplementation with n-3 fatty acids increases gluconeogenesis from glycerol but not hepatic glucose production in patients with non-insulin-dependent diabetes mellitus.  Am J Clin Nutr. 1995;  61 121-126
• 24 Rasmussen O W, Thomsen C, Hansen K W, Vesterlund M, Winther E, Hermansen K. Effects on blood pressure, glucose, and lipid levels of a high-monounsaturated fat diet compared with a high-carbohydrate diet in NIDDM subjects.  Diabetes Care. 1993;  16 1565-1571
• 25 Ryan M, McInerney D, Owens D, Collins P, Johnson A, Tomkin G H. Diabetes and the Mediterranean diet: a beneficial effect of oleic acid on insulin sensitivity, adipocyte glucose transport and endothelium-dependent vasoreactivity.  QJM. 2000;  93 85-91
• 26 Sirtori C R, Crepaldi G, Manzato E, Mancini M, Rivellese A, Paoletti R, Pazzucconi F, Pamparana F, Stragliotto E. One-year treatment with ethyl esters of n-3 fatty acids in patients with hypertriglyceridemia and glucose intolerance: reduced triglyceridemia, total cholesterol and increased HDL-C without glycemic alterations.  Atherosclerosis. 1998;  137 419-427
• 27 Stiefel P, Ruiz-Gutierrez V, Gajon E, Acosta D, Garcia-Donas M A, Madrazo J, Villar J, Carneado J. Sodium transport kinetics, cell membrane lipid composition, neural conduction and metabolic control in type 1 diabetic patients. Changes after a low-dose n-3 fatty acid dietary intervention.  Ann Nutr Metab. 1999;  43 113-120
• 28 Thomsen C, Rasmussen O, Christiansen C, Pedersen E, Vesterlund M, Storm H, Ingerslev J, Hermansen K. Comparison of the effects of a monounsaturated fat diet and a high carbohydrate diet on cardiovascular risk factors in first degree relatives to type-2 diabetic subjects.  Eur J Clin Nutr. 1999;  53 818-823
• 29 Vessby B, Boberg M. Dietary supplementation with n-3 fatty acids may impair glucose homeostasis in patients with non-insulin-dependent diabetes mellitus.  J Intern Med. 1990;  228 165-171
• 30 Vessby B, Karlstrom B, Boberg M, Lithell H, Berne C. Polyunsaturated fatty acids may impair blood glucose control in type 2 diabetic patients.  Diabet Med. 1992;  9 126-133